Nandrolone: Uses, Benefits & Side Effects

Adverse Effects Observed After Initiation of Empagliflozin (10 mg daily)

Empagliflozin is a sodium‑glucose co‑transporter‑2 (SGLT‑2) inhibitor that lowers blood glucose by increasing urinary glucose excretion. The most common clinical sequelae are related to its mechanism of action – osmotic diuresis, glucosuria and a modest reduction in plasma osmolality. The table below summarizes the adverse events that were documented after the first dose (10 mg daily) was started.